tirzepatide and anavar Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes Obesity: A Mini-Review Tirzepatide induces a thermogenic-like amino

Uncertainty remains about whether it may have the same effect in humans

Wegovy (Semaglutide) and Zepbound (Tirzepatide) are FDA-approved, once-weekly injectables designed for adults with obesity or those who are overweight with weight-related health conditions

Follow me on Instagram: @izabellawentzpharmd Get my FREE weekly thyroid & gut health newsletter: Sign up here Subscribe & Review: If you loved this episode, please leave a review on Apple Podcasts or rate it on Spotify

Note: Local policies vary, and some specialist services may not support continuation of incretin-based therapies in people with type 1 diabetes if initiated outside NHS pathways

The biological mechanisms targeted by the Glycotide ingredients require consistent, long-term support